Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBS for Intracerebral Hemorrhage
NCT07080632Not yet recruiting
- Sponsor
- Tongji Hospital
- Start
- Oct 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of calculus bovis sativus in intracerebral hemorrhage (ICH) (2 arms), sponsored by Tongji Hospital. Primary endpoints: Modified Rankin Scale at 12 weeks, National Institute of Health Stroke Scale at 12 weeks and 1 more. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
calculus bovis sativus
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT07080632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07080632.